Results
Latest quarterly results
Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.
SectorAll 3892Healthcare 878Financial Services 629Technology 560Industrials 517Consumer Cyclical 330Basic Materials 232Energy 196Communication Services 168Real Estate 161Consumer Defensive 134Utilities 87
| Company | Sector | Reported | Quarter | Revenue | Rev. YoY | Net income | NI YoY | EPS | EPS YoY | Op. margin | Margin chg. | Market cap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TELOTelomir Pharmaceuticals, Inc. | Healthcare | Nov 6 | Sep '26 | $0.0M | n/m | −$1.0M | n/m | −$0.01 | n/m | — | — | $31M |
| IGCIGC Pharma, Inc. | Healthcare | Nov 6 | Sep '26pending | $0.3M† | n/m | — | — | — | — | — | — | $22M |
| BIAFbioAffinity Technologies, Inc. | Healthcare | Nov 6 | Sep '26 | $1.0M | 0.0% | −$5.0M | n/m | −$5.89 | n/m | -328.0% | −169.4 pp | $12M |
| BIVIBioVie Inc. | Healthcare | Nov 6 | Sep '26 | $0.0M | n/m | −$6.0M | n/m | −$0.68 | n/m | — | — | $11M |
| ALGSAligos Therapeutics, Inc. | Healthcare | Nov 6 | Sep '26 | $3.0M | +200.0% | −$22.0M | n/m | −$2.09 | n/m | -763.0% | — | $8M |
| SNGXSoligenix, Inc. | Healthcare | Nov 6 | Sep '26 | $0.0M | n/m | −$1.0M | n/m | −$0.05 | n/m | — | — | $7M |
| CDIOCardio Diagnostics Holdings Inc. | Healthcare | Nov 6 | Sep '26 | $0.0M | n/m | −$2.0M | n/m | −$0.59 | n/m | — | — | $5M |
| CELZCreative Medical Technology Holdings, Inc. | Healthcare | Nov 6 | Sep '26 | $0.0M | n/m | −$3.0M | n/m | −$0.40 | n/m | — | — | $4M |
| ERNAErnexa Therapeutics Inc. | Healthcare | Nov 6 | Sep '26 | $0.0M | n/m | −$3.0M | n/m | −$1.89 | n/m | — | — | $3M |
| MBIOMustang Bio, Inc. | Healthcare | Nov 6 | Sep '26 | $0.0M | n/m | −$1.0M | n/m | −$0.14 | n/m | — | — | $3M |
| MDCXMedicus Pharma Ltd. | Healthcare | Nov 6 | Sep '26 | $0.0M | n/m | −$15.0M | n/m | −$11.64 | n/m | — | — | $2M |
| CIThe Cigna Group | Healthcare | Nov 5 | Sep '26 | $73.68B | +5.6% | $1.44B | −22.8% | $5.47 | −21.5% | 3.3% | −0.5 pp | $77.5B |
| CAHCardinal Health, Inc. | Healthcare | Nov 5 | Sep '26 | $67.51B | +5.5% | $554M | +23.1% | $2.38 | +26.6% | 1.1% | +0.1 pp | $64.5B |
| BDXBecton, Dickinson and Company | Healthcare | Nov 5 | Sep '26 | $5.27B | −10.5% | $696M | +41.2% | $2.54 | +47.7% | 19.6% | +7.7 pp | $58.7B |
| NTRANatera, Inc. | Healthcare | Nov 5 | Sep '26 | $794M | +34.1% | −$60.0M | n/m | −$0.42 | n/m | -8.6% | +7.9 pp | $41.7B |
| MTDMettler-Toledo International, Inc. | Healthcare | Nov 5 | Sep '26 | $1.09B | +6.2% | $246M | +13.4% | $12.29 | +16.3% | 28.3% | +0.2 pp | $34.1B |
| ZTSZoetis Inc. | Healthcare | Nov 5 | Sep '26 | $2.39B | −0.4% | $591M | −18.0% | $1.44 | −11.7% | 36.1% | −2.9 pp | $33.9B |
| VTRSViatris Inc. | Healthcare | Nov 5 | Sep '26 | $3.75B | −0.3% | −$325M | n/m | −$0.28 | n/m | 7.0% | +0.3 pp | $23.4B |
| GHGuardant Health, Inc. | Healthcare | Nov 5 | Sep '26 | $361M | +36.2% | −$124M | n/m | −$0.93 | n/m | -36.8% | +0.6 pp | $19.4B |
| SOLVSolventum Corporation | Healthcare | Nov 5 | Sep '26 | $1.95B | −7.0% | −$12.0M | −100.9% | −$0.07 | −101.0% | 3.5% | −3.0 pp | $14.6B |
| HALOHalozyme Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $493M | +39.3% | $247M | +41.1% | $2.01 | +40.6% | 59.8% | −1.7 pp | $10.9B |
| GMEDGlobus Medical, Inc. | Healthcare | Nov 5 | Sep '26 | $764M | −0.7% | $141M | +18.5% | $1.04 | +18.2% | 23.3% | +5.7 pp | $9.3B |
| PTGXProtagonist Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $274M | +5,380% | $220M | n/m | $3.07 | n/m | 79.6% | +1064.7 pp | $8.1B |
| OSCROscar Health, Inc. | Healthcare | Nov 5 | Sep '26 | $5.14B | +72.1% | $167M | n/m | $0.49 | n/m | 3.5% | +7.8 pp | $7.7B |
| TXG10x Genomics, Inc. | Healthcare | Nov 5 | Sep '26 | $151M | +1.3% | −$19.0M | n/m | −$0.15 | n/m | -10.7% | +11.0 pp | $6.8B |
| LNTHLantheus Holdings, Inc. | Healthcare | Nov 5 | Sep '26 | $390M | +1.6% | $22.0M | −21.4% | $0.33 | −19.5% | 8.3% | −3.1 pp | $6.7B |
| TFXTeleflex Incorporated | Healthcare | Nov 5 | Sep '26 | $568M | −37.8% | $927M | n/m | $22.28 | n/m | 18.6% | +21.8 pp | $6.3B |
| DOCSDoximity, Inc. | Healthcare | Nov 5 | Sep '26 | $175M | +3.6% | $35.0M | −43.5% | $0.18 | −41.9% | 25.2% | −12.6 pp | $5.5B |
| HAEHaemonetics Corporation | Healthcare | Nov 5 | Sep '26 | $358M | +9.5% | $46.0M | +17.9% | $1.00 | +23.5% | 21.0% | +0.5 pp | $5.5B |
| LFSTLifeStance Health Group, Inc. | Healthcare | Nov 5 | Sep '26 | $456M | +25.3% | $22.0M | +2,100% | $0.06 | n/m | 7.3% | +5.2 pp | $5.4B |
| CONConcentra Group Holdings Parent, Inc. | Healthcare | Nov 5 | Sep '26 | $622M | +8.6% | $66.0M | +37.5% | $0.52 | +40.5% | 18.5% | +2.0 pp | $5.4B |
| ICUIICU Medical, Inc. | Healthcare | Nov 5 | Sep '26 | $560M | +4.3% | $27.0M | n/m | $1.07 | n/m | 9.3% | +6.8 pp | $4.4B |
| AMLXAmylyx Pharmaceuticals, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$45.0M | n/m | −$0.38 | n/m | — | — | $3.5B |
| IOVAIovance Biotherapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $121M | +80.6% | −$22.0M | n/m | −$0.05 | n/m | -19.7% | +113.3 pp | $3.5B |
| ELVNEnliven Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$28.0M | n/m | −$0.36 | n/m | — | — | $3.4B |
| PLSEPulse Biosciences, Inc | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$23.0M | n/m | −$0.32 | n/m | — | — | $3.3B |
| TMDXTransMedics Group, Inc. | Healthcare | Nov 5 | Sep '26 | $203M | +41.0% | $17.0M | −29.2% | $0.46 | −30.3% | 13.9% | −2.3 pp | $3.3B |
| PRVAPrivia Health Group, Inc. | Healthcare | Nov 5 | Sep '26 | $657M | +13.3% | $13.0M | +85.7% | $0.10 | +100.0% | 3.1% | +0.7 pp | $3.2B |
| GRDNGuardian Pharmacy Services, Inc. | Healthcare | Nov 5 | Sep '26 | $371M | −1.6% | $19.0M | +90.0% | $0.29 | +93.3% | 6.8% | +2.3 pp | $3.2B |
| XERSXeris Biopharma Holdings, Inc. | Healthcare | Nov 5 | Sep '26 | $107M | +44.6% | $11.0M | +1,000% | $0.06 | n/m | 15.8% | +6.7 pp | $3.1B |
| DYNDyne Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$194M | n/m | −$1.06 | n/m | — | — | $3.0B |
| IRTCiRhythm Holdings, Inc. | Healthcare | Nov 5 | Sep '26 | $222M | +15.0% | −$30.0M | n/m | −$0.90 | n/m | -14.7% | −12.6 pp | $3.0B |
| VCELVericel Corporation | Healthcare | Nov 5 | Sep '26 | $85.0M | +25.0% | $14.0M | +180.0% | $0.27 | +170.0% | 14.3% | +9.2 pp | $3.0B |
| IRONDisc Medicine, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$60.0M | n/m | −$1.53 | n/m | — | — | $2.9B |
| CELCCelcuity Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$73.0M | n/m | −$1.33 | n/m | — | — | $2.8B |
| PBHPrestige Consumer Healthcare Inc. | Healthcare | Nov 5 | Sep '26 | $336M | +22.6% | $25.0M | −40.5% | $0.53 | −38.4% | 24.0% | −5.1 pp | $2.3B |
| CLDXCelldex Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$76.0M | n/m | −$0.96 | n/m | — | — | $2.2B |
| PVLAPalvella Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$25.0M | n/m | −$1.70 | n/m | — | — | $2.1B |
| VERAVera Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $10.0M | n/m | −$94.0M | n/m | −$1.30 | n/m | -931.2% | — | $1.9B |
| ZBIOZenas BioPharma, Inc. | Healthcare | Nov 5 | Sep '26 | $10.0M | n/m | −$109M | n/m | −$1.65 | n/m | — | — | $1.9B |
- Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
- YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
- pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.